Neuronetics Overcomes Negative Panel Review To Earn Clearance For NeuroStar
This article was originally published in The Gray Sheet
Executive Summary
FDA cleared Neuronetics' NeuroStar transcranial magnetic stimulation system for drug-resistant depression, despite a negative advisory panel review, based on a pivotal study subset analysis